{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:55:40Z","timestamp":1789480540130,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Organ transplant recipients receiving immunosuppressive therapy have a higher risk of developing anogenital HPV-related (pre)malignancies. This study aims to determine the age-dependent anogenital hrHPV prevalence in transplanted patients and to investigate various risk factors within this high-risk patient group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Women (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009201) after kidney (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200998), liver (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200993), and combined (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910) transplantation were tested and genotyped for hrHPV in the anal and cervical regions. Medical records and a questionnaire assessed sexual behaviour, medical treatment history, and demographic data.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among our cohort the median age was 52 years (range 18\u201378), the prevalence of cervical hrHPV infection was 15.9% (32\/201), with no significant difference observed between liver and kidney transplant recipients. Increased hrHPV prevalence was not associated with transplant-specific risk factors such as type and duration of immunosuppressive therapy, whereas typical risk factors such as sexual behaviour conferred increased risk. Anal hrHPV had an overall prevalence of 20.3%, and the co-prevalence of hrHPV detected at both anal and cervical sites was 68.8%. 90% of the patients with cervical hrHPV infection (29\/32) attended clinical follow-up and high-grade intraepithelial neoplasia was detected in four women (3x CIN2+\/ 1x VaIN3).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Compared to the general population, our study shows an increased cervical HPV prevalence in transplanted patients above 30 years. In addition, the baseline risk for infection with anal hrHPV is increased, suggesting that additional screening in cervical hrHPV-positive transplanted patients may be beneficial to detect (pre)invasive lesions in the anal region.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-025-03813-0","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:30:07Z","timestamp":1751517007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anogenital high-risk HPV prevalence and screening considerations in female transplant recipients: a cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"Christoph","family":"Hillen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Sachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Prieske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Schmalfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"L\u00fctgehetmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Sterneck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte A.","family":"Kluger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas M.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eik","family":"Vettorazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linn","family":"Woelber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"3813_CR1","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1056\/NEJMsr2030640","volume":"385","author":"V Bouvard","year":"2021","unstructured":"Bouvard V, Wentzensen N, Mackie A, et al. The IARC perspective on cervical Cancer screening. N Engl J Med. 2021;385:1908\u201318. https:\/\/doi.org\/10.1056\/NEJMsr2030640.","journal-title":"N Engl J Med"},{"key":"3813_CR2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.virol.2013.07.015","volume":"445","author":"D Bzhalava","year":"2013","unstructured":"Bzhalava D, Guan P, Franceschi S, et al. A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. Virology. 2013;445:224\u201331. https:\/\/doi.org\/10.1016\/j.virol.2013.07.015.","journal-title":"Virology"},{"key":"3813_CR3","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S1473-3099(19)30164-1","volume":"19","author":"C Lin","year":"2019","unstructured":"Lin C, Slama J, Gonzalez P, et al. Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis. Lancet Infect Dis. 2019;19:880\u201391. https:\/\/doi.org\/10.1016\/S1473-3099(19)30164-1.","journal-title":"Lancet Infect Dis"},{"key":"3813_CR4","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1111\/ajt.15292","volume":"19","author":"JB Liao","year":"2019","unstructured":"Liao JB, Fisher CE, Madeleine MM. Gynecologic cancers and solid organ transplantation. Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg. 2019;19:1266\u201377. https:\/\/doi.org\/10.1111\/ajt.15292.","journal-title":"Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg"},{"key":"3813_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/ijc.33185","volume":"148","author":"GM Clifford","year":"2021","unstructured":"Clifford GM, Georges D, Shiels MS, et al. A meta-analysis of anal cancer incidence by risk group: toward a unified anal cancer risk scale. Int J Cancer. 2021;148:38\u201347. https:\/\/doi.org\/10.1002\/ijc.33185.","journal-title":"Int J Cancer"},{"key":"3813_CR6","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1111\/ajt.12472","volume":"13","author":"MM Madeleine","year":"2013","unstructured":"Madeleine MM, Finch JL, Lynch CF, et al. HPV-Related cancers after solid organ transplantation in the united States. Am J Transpl. 2013;13:3202\u20139. https:\/\/doi.org\/10.1111\/ajt.12472.","journal-title":"Am J Transpl"},{"key":"3813_CR7","first-page":"433","volume":"22","author":"S Ghazizadeh","year":"2011","unstructured":"Ghazizadeh S, Lessan-Pezeshki M, Nahayati MA. Human papilloma virus infection in female kidney transplant recipients. Saudi J Kidney Dis Transpl Off Publ Saudi Cent Organ Transpl Saudi Arab. 2011;22:433\u20136.","journal-title":"Saudi J Kidney Dis Transpl Off Publ Saudi Cent Organ Transpl Saudi Arab"},{"key":"3813_CR8","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/tri.12339","volume":"27","author":"M Gr\u0105t","year":"2014","unstructured":"Gr\u0105t M, Gr\u0105t K, Ho\u0142\u00f3wko W, et al. Initial prevalence of anal human papilloma virus infection in liver transplant recipients. Transpl Int Off J Eur Soc Organ Transpl. 2014;27:816\u201323. https:\/\/doi.org\/10.1111\/tri.12339.","journal-title":"Transpl Int Off J Eur Soc Organ Transpl"},{"key":"3813_CR9","doi-asserted-by":"publisher","first-page":"e12714","DOI":"10.1111\/tid.12714","volume":"19","author":"CA de Oliveira Martins","year":"2017","unstructured":"de Oliveira Martins CA, Guimar\u00e3es ICCDV, Velarde LGC. Relationship between the risk factors for human papillomavirus infection and lower genital tract precursor lesion and cancer development in female transplant recipients. Transpl Infect Dis. 2017;19:e12714. https:\/\/doi.org\/10.1111\/tid.12714.","journal-title":"Transpl Infect Dis"},{"key":"3813_CR10","doi-asserted-by":"publisher","unstructured":"Larsen HK, H\u00e6dersdal M, Thomsen LT et al. (2020) Risk of anal High-grade squamous intraepithelial lesions among renal transplant recipients compared with immunocompetent controls. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa781","DOI":"10.1093\/cid\/ciaa781"},{"key":"3813_CR11","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/dc.24180","volume":"47","author":"J Eleut\u00e9rio","year":"2019","unstructured":"Eleut\u00e9rio J, Cavalcante LR, Gon\u00e7alves AKS, et al. Prevalence of high-risk HPV and atypia in liquid-based cytology of cervical and intra-anal specimens from kidney-transplanted women. Diagn Cytopathol. 2019;47:783\u20137. https:\/\/doi.org\/10.1002\/dc.24180.","journal-title":"Diagn Cytopathol"},{"key":"3813_CR12","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.transproceed.2009.03.015","volume":"41","author":"M Veroux","year":"2009","unstructured":"Veroux M, Corona D, Scalia G, et al. Surveillance of human papilloma virus infection and cervical Cancer in kidney transplant recipients: preliminary data. Transpl Proc. 2009;41:1191\u20134. https:\/\/doi.org\/10.1016\/j.transproceed.2009.03.015.","journal-title":"Transpl Proc"},{"key":"3813_CR13","doi-asserted-by":"publisher","unstructured":"Wielgos A, Pietrzak B, Sikora M, et al. Human papillomavirus (HPV) DNA detection using Self-Sampling devices in women undergoing long term immunosuppressive therapy. Viruses. 2020;12. https:\/\/doi.org\/10.3390\/v12090962.","DOI":"10.3390\/v12090962"},{"key":"3813_CR14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/ajt.13053","volume":"15","author":"Ka Meeuwis","year":"2015","unstructured":"Meeuwis Ka, Hilbrands P, IntHout LB J, et al. Cervicovaginal HPV infection in female renal transplant recipients: an observational, Self-Sampling based, cohort study. Am J Transpl. 2015;15:723\u201333. https:\/\/doi.org\/10.1111\/ajt.13053.","journal-title":"Am J Transpl"},{"key":"3813_CR15","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/j.transproceed.2008.05.074","volume":"40","author":"DM Paternoster","year":"2008","unstructured":"Paternoster DM, Cester M, Resente C, et al. Human papilloma virus infection and cervical intraepithelial neoplasia in transplanted patients. Transpl Proc. 2008;40:1877\u201380. https:\/\/doi.org\/10.1016\/j.transproceed.2008.05.074.","journal-title":"Transpl Proc"},{"key":"3813_CR16","unstructured":"Hillemanns P, Friese K, Dannecker C. (2020) S3-Leitlinie Pr\u00e4vention des Zervixkarzinoms. 240."},{"key":"3813_CR17","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1056\/NEJMoa2201048","volume":"386","author":"JM Palefsky","year":"2022","unstructured":"Palefsky JM, Lee JY, Jay N, et al. Treatment of anal High-Grade squamous intraepithelial lesions to prevent anal Cancer. N Engl J Med. 2022;386:2273\u201382. https:\/\/doi.org\/10.1056\/NEJMoa2201048.","journal-title":"N Engl J Med"},{"key":"3813_CR18","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/ijc.34850","volume":"154","author":"EA Stier","year":"2024","unstructured":"Stier EA, Clarke MA, Deshmukh AA, et al. International anal neoplasia society\u2019s consensus guidelines for anal cancer screening. Int J Cancer. 2024;154:1694\u2013702. https:\/\/doi.org\/10.1002\/ijc.34850.","journal-title":"Int J Cancer"},{"key":"3813_CR19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","volume":"7","author":"S de Sanjos\u00e9","year":"2007","unstructured":"de Sanjos\u00e9 S, Diaz M, Castellsagu\u00e9 X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7:453\u20139. https:\/\/doi.org\/10.1016\/S1473-3099(07)70158-5.","journal-title":"Lancet Infect Dis"},{"key":"3813_CR20","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1002\/jmv.21910","volume":"82","author":"T Iftner","year":"2010","unstructured":"Iftner T, Eberle S, Iftner A, et al. Prevalence of low-risk and high-risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age: an epidemiological observational study. J Med Virol. 2010;82:1928\u201339. https:\/\/doi.org\/10.1002\/jmv.21910.","journal-title":"J Med Virol"},{"key":"3813_CR21","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/ijc.28783","volume":"135","author":"A Luyten","year":"2014","unstructured":"Luyten A, Buttmann-Schweiger N, Luyten K, et al. Early detection of CIN3 and cervical cancer during long-term follow-up using HPV\/Pap smear co-testing and risk-adapted follow-up in a locally organised screening programme. Int J Cancer. 2014;135:1408\u201316. https:\/\/doi.org\/10.1002\/ijc.28783.","journal-title":"Int J Cancer"},{"key":"3813_CR22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.15585\/mmwr.mm7012a2","volume":"70","author":"HG Rosenblum","year":"2021","unstructured":"Rosenblum HG, Lewis RM, Gargano JW, et al. Declines in prevalence of human papillomavirus Vaccine-Type infection among females after introduction of Vaccine - United States, 2003\u20132018. MMWR Morb Mortal Wkly Rep. 2021;70:415\u201320. https:\/\/doi.org\/10.15585\/mmwr.mm7012a2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"3813_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1743-422X-9-117","volume":"9","author":"B Pietrzak","year":"2012","unstructured":"Pietrzak B, Mazanowska N, Ekiel AM, et al. Prevalence of high-risk human papillomavirus cervical infection in female kidney graft recipients: an observational study. Virol J. 2012;9:117. https:\/\/doi.org\/10.1186\/1743-422X-9-117.","journal-title":"Virol J"},{"key":"3813_CR24","doi-asserted-by":"publisher","first-page":"e692","DOI":"10.1093\/cid\/ciac581","volume":"76","author":"F Wei","year":"2023","unstructured":"Wei F, Goodman MT, Xia N, et al. Incidence and clearance of anal human papillomavirus infection in 16 164 individuals, according to human immunodeficiency virus status, sex, and male sexuality: an international pooled analysis of 34 longitudinal studies. Clin Infect Dis Off Publ Infect Dis Soc Am. 2023;76:e692\u2013701. https:\/\/doi.org\/10.1093\/cid\/ciac581.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"3813_CR25","doi-asserted-by":"publisher","unstructured":"Freeman MJ, Yang Q, Cherney-Stafford L et al. (2024) Analysis of >\u200915 000 solid organ transplant recipients reveals Nonanal genitourinary HPV-related disease as highest risk predictor for anal squamous intraepithelial lesions\/anal Cancer. Transplantation. https:\/\/doi.org\/10.1097\/TP.0000000000004930","DOI":"10.1097\/TP.0000000000004930"},{"key":"3813_CR26","doi-asserted-by":"publisher","unstructured":"Danziger-Isakov L, Kumar D, Practice TAIC. of (2019) Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant 33:e13563. https:\/\/doi.org\/10.1111\/ctr.13563","DOI":"10.1111\/ctr.13563"},{"key":"3813_CR27","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.cmi.2021.04.031","volume":"27","author":"M Arbyn","year":"2021","unstructured":"Arbyn M, Simon M, Peeters E, et al. 2020 List of human papillomavirus assays suitable for primary cervical cancer screening. Clin Microbiol Infect. 2021;27:1083\u201395. https:\/\/doi.org\/10.1016\/j.cmi.2021.04.031.","journal-title":"Clin Microbiol Infect"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03813-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-025-03813-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03813-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:30:08Z","timestamp":1751517008000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-025-03813-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3813"],"URL":"https:\/\/doi.org\/10.1186\/s12905-025-03813-0","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"14 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Hamburg Medical Association Ethics Committee approved the study in June 2019 (Ethics vote: PV6011).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors of this manuscript have conflicts of interest to disclose, L Woelber has given talks or received honoraria from Roche, Eisai, Novartis, MSD, Seagen, GSK, Astra Zeneca, Pfizer, Lumenis, TEVA, pomedicis, and Omniamed and has served as consultant or received consulting fees from GSK, Roche, Eisai, MSD, and Seagen. Her research was supported by grants from DKH, Hamburger Krebsgesellschaft, medac oncology, and Roche diagnostics. K Prieske reports personal fees from AstraZeneca, MSD, Molecular health, GSK, Roche, and Clovis Oncology outside the submitted work. However, the opinions expressed in this article are those of the authors and do not reflect those of any of the companies mentioned above.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"290"}}